Clinical Trial Update: Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS) [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-principle trial of TC-6499 for constipation-predominant irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• TC-6499

Snippet

Sponsor: Targacept Inc. | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED